We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

HUMAN GMBH

HUMAN offers a broad portfolio of in vitro diagnostic products with more than 400 products in 12 areas covering the w... read more Featured Products: More products

Download Mobile App





HUMAN Diagnostics Launches Next Generation Clinical Chemistry Instruments

By LabMedica International staff writers
Posted on 04 Feb 2025
Print article
Image
Image

HUMAN Diagnostics (Wiesbaden, Germany) is launching its next-generation clinical chemistry instruments at Medlab Middle East 2025. The launch is under the motto “Primed for Precision. Built for Performance” and will spotlight the next-generation HumaStar 300SR, HumaStar 200, and the HumaLyzer Primus NG, offering laboratories cutting-edge performance, enhanced efficiency, and robust reliability. These instruments cater to diverse throughput needs, empowering labs to deliver accurate and timely results critical to patient care.

The updated HumaStar 300SR and HumaStar 200 instruments offer improved performance and reliability with an advanced cuvette wash station and, now new, clot detection (HumaStar 300SR only). The upgraded pipetting unit ensures higher precision for low volumes and better repeatability, while V-shaped reaction cuvettes reduce reagent use and operating costs. Additionally, an integrated 2D barcode scanner simplifies the import of QC and calibration target values, streamlining operations; the 3-color LED status illumination provides intuitive and easy monitoring.

The HumaLyzer Primus NG is a user-friendly, semi-automated solution that is ideal for laboratories in resource-limited settings with a large 7-inch touchscreen interface enhancing usability. Visitors to HUMAN’s booth can explore these next-gen instruments and view live demonstrations that showcase their capabilities and ease of use. Additionally, HUMAN is also showcasing the HumaCombilyzer portable, semi-automated urine test strip analyzer which is ideal for in-office and more rural healthcare settings. Alongside, HUMAN is showcasing HumaCombina urine test strips which enable fast and effortless assessment of urine status, supporting the detection of pathological changes.

“HUMAN’s clinical chemistry instruments have long been trusted for their precision and reliability. With this launch, we’re setting new standards for laboratory diagnostics by combining German engineering excellence with the latest technological advancements,” said Dr. Christine Hettmann-Dreuw, VP of Marketing & Strategic Purchase at HUMAN Diagnostics.

Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
FOB+Transferrin+Calprotectin+Lactoferrin Test
CerTest FOB+Transferrin+Calprotectin+Lactoferrin Combo Test
New
TRAb Immunoassay
Chorus TRAb

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.